Lakefront Biotherapeutics (LKFT) EBT (2014 - 2026)
Lakefront Biotherapeutics (LKFT) reported EBT of $16.3 million for Q1 2026, up 109.93% year-over-year from $7.8 million in Q1 2025, and down 98.21% quarter-over-quarter from $911.6 million in Q4 2025.
Lakefront Biotherapeutics (LKFT) EBT (2014 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has 13 years of EBT data on file, last reported at $16.3 million in Q1 2026.
- EBT for Q1 2026 came in at $16.3 million, up 109.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $541.1 million (up 378.01% YoY), and the FY2025 annual result was $350.2 million, up 10723.83% from the prior year.
- EBT slipped to $16.3 million in Q1 2026 per LKFT's latest filing, from $911.6 million in the prior quarter.
- Over five years, EBT peaked at $911.6 million in Q4 2025 and troughed at -$564.3 million in Q3 2025.
- A 5-year average of $10.5 million and a median of -$13.9 million in 2022 frame the typical range for EBT.
- The sharpest annual moves came in 2022 and 2025: EBT sank 1466.13% in 2022, then soared 4382.72% in 2025.
- A 5-year view of EBT shows it stood at -$64.6 million in 2022, then gained by 28.77% to -$46.0 million in 2023, then surged by 144.21% to $20.3 million in 2024, then soared by 4382.72% to $911.6 million in 2025, then plunged by 98.21% to $16.3 million in 2026.
- Business Quant data shows LKFT's EBT at $16.3 million in Q1 2026, $911.6 million in Q4 2025, and -$564.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -15.31 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -3.18 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -56.48 Mn |
| 10 | Lakefront Biotherapeutics | 9.64 Bn | 9.64 Bn | 1.97 Mn | 16.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.34 Mn |
| Dec 31, 2025 | 911.63 Mn |
| Sep 30, 2025 | -564.27 Mn |
| Jun 30, 2025 | 177.44 Mn |
| Mar 31, 2025 | -164.48 Mn |
| Dec 31, 2024 | 20.34 Mn |
| Sep 30, 2024 | -102.41 Mn |
| Jun 30, 2024 | 51.91 Mn |
| Mar 31, 2024 | 24.92 Mn |
| Dec 31, 2023 | -46.00 Mn |
| Sep 30, 2023 | -15.48 Mn |
| Jun 30, 2023 | -14.70 Mn |
| Mar 31, 2023 | -12.21 Mn |
| Dec 31, 2022 | -64.58 Mn |
| Sep 30, 2022 | -37.87 Mn |
| Mar 31, 2022 | -13.00 Mn |
| Dec 31, 2021 | 4.73 Mn |
| Jun 30, 2021 | 41.99 Mn |
| Mar 31, 2021 | -15.29 Mn |
| Dec 31, 2020 | -212.94 Mn |